Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

MyNCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2014 7
2015 63
2016 58
2017 30
2018 15
2019 6
2020 0
Text availability
Article attribute
Article type
Publication date

Search Results

161 results
Results by year
Filters applied: . Clear all
Page 1
Simeprevir with pegylated interferon alfa 2a plus ribavirin in treatment-naive patients with chronic hepatitis C virus genotype 1 infection (QUEST-1): a phase 3, randomised, double-blind, placebo-controlled trial.
Jacobson IM, Dore GJ, Foster GR, Fried MW, Radu M, Rafalsky VV, Moroz L, Craxi A, Peeters M, Lenz O, Ouwerkerk-Mahadevan S, De La Rosa G, Kalmeijer R, Scott J, Sinha R, Beumont-Mauviel M. Jacobson IM, et al. Lancet. 2014 Aug 2;384(9941):403-13. doi: 10.1016/S0140-6736(14)60494-3. Epub 2014 Jun 4. Lancet. 2014. PMID: 24907225 Clinical Trial.
Genotypic resistance testing of HCV - is there a clinical need?
Walker A, Kaiser R, Bartenschlager R, Timm J. Walker A, et al. GMS Infect Dis. 2016 Aug 4;4:Doc05. doi: 10.3205/id000023. eCollection 2016. GMS Infect Dis. 2016. PMID: 30671319 Free PMC article. Review.
Early HCV viral kinetics under DAAs may optimize duration of therapy in patients with compensated cirrhosis.
Gambato M, Canini L, Lens S, Graw F, Perpiñan E, Londoño MC, Uprichard SL, Mariño Z, Reverter E, Bartres C, González P, Pla A, Costa J, Burra P, Cotler SJ, Forns X, Dahari H. Gambato M, et al. Liver Int. 2019 May;39(5):826-834. doi: 10.1111/liv.14014. Epub 2018 Dec 28. Liver Int. 2019. PMID: 30499631
161 results
Jump to page
Feedback